Upgrade to SI Premium - Free Trial

Rigel Pharma (RIGL) Tops Q3 EPS by 146c

November 4, 2025 4:34 PM

Rigel Pharma (NASDAQ: RIGL) reported Q3 EPS of $1.46. Revenue for the quarter came in at $69.46 million.

For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.

Categories

Earnings